Combinostics at ECTRIMS 2022
Did we miss you at ECRIMS 2022? Schedule a meeting with our team to learn more about our cNeuro® suite, including the cMRI™ and cDSI™ applications, and new clinically focused cMRI report for multiple sclerosis, as well as reports for dementia, traumatic brain injuries, and epilepsy. Our complete AI software solution supports entire patient care pathways of multiple sclerosis and other major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring.
Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.
Our cNeuro® suite puts the focus on patients by providing clinicians with objective, systematic insights for confident, evidence-based diagnostic and management decisions.
Patient data from multiple sources are integrated and compared with data from previous patients and healthy controls: demographic information, imaging (cMRI) and other biomarkers, clinical characteristics, and neuropsychology tests.
Applications in the cNeuro® suite:
Our AI-driven software tools support early detection, differential diagnosis, prediction of progression, and monitoring of neurodegenerative disorders.
cMRI provides fully automated brain MRI quantification for increased throughput, greater objectivity, and high-quality reporting for improved patient care.